Publications
Showing 91-105 from 1626 publications.
- Elosua R. A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease.
Nat. Genet. 2015 Oct; 47(10): 1121-30
IF: 29.352
- Bayés-Genís A, de Antonio M, Vila J, Peñafiel J, Galán A, Barallat J, Zamora E, Urrutia A, Lupón J. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
J. Am. Coll. Cardiol. 2014 Jan; 63(2): 158-66
IF: 16.503, Quartile: 1, Decile: 1
- Zamora E, Lupón J, de Antonio M, Vila J, Peñafiel J, Galán A, Urrutia A, Domingo M, Bayés-Genís A. Long-term prognostic value for patients with chronic heart failure of estimated glomerular filtration rate calculated with the new CKD-EPI equations containing cystatin C.
Clin. Chem. 2014 Mar; 60(3): 481-9
IF: 7.911, Quartile: 1, Decile: 1
- Lupón J, de Antonio M, Vila J, Peñafiel J, Galán A, Zamora E, Urrutia A, Bayés-Genís A. Development of a novel heart failure risk tool: the barcelona bio-heart failure risk calculator (BCN bio-HF calculator).
PLoS ONE 2014; 9(1): e85466
IF: 3.234, Quartile: 1
- Lupón J, Januzzi JL, de Antonio M, Vila J, Peñafilel J, Bayés-Genís A. Validation of the Barcelona Bio-Heart Failure Risk Calculator in a cohort from Boston.
Rev Esp Cardiol (Engl Ed) 2015 Jan; 68(1): 80-1
IF: 3.792, Quartile: 2
- Barón Esquivias G, Escolar Albaladejo G, Zamorano JL, Betegón Nicolás L, Canal Fontcuberta C, de Salas-Cansado M, Rubio-Rodríguez D, Rubio-Terrés C. Cost-effectiveness Analysis Comparing Apixaban and Acenocoumarol in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation in Spain.
Rev Esp Cardiol (Engl Ed) 2015 Aug; 68(8): 680-90
IF: 3.792, Quartile: 2
- Villalba Martinez G, Navalpotro Gomez I, Serrano Perez L, Gonzalez Ortiz S, Fernández-Candil JL, Steinhauer EG. Surgical Position, Cause of Extracranial Internal Carotid Artery Dissection, Presenting as Pourfour Du Petit Syndrome: Case Report and Literature Review.
Turk Neurosurg 2015; 25(4): 666-9
IF: 0, Quartile: 4
- Cuadrado-Godia E, Regueiro A, Núñez J, Díaz-Ricard M, Novella S, Oliveras A, Valverde MA, Marrugat J, Ois A, Giralt-Steinhauer E, Sanchis J, Escolar G, Hermenegildo C, Heras M, Roquer J. Endothelial Progenitor Cells Predict Cardiovascular Events after Atherothrombotic Stroke and Acute Myocardial Infarction. A PROCELL Substudy.
PLoS ONE 2015; 10(9): e0132415
IF: 3.534, Quartile: 1
- Velescu A, Clarà A, Peñafiel J, Ramos R, Martí R, Grau M, Dégano IR, Marrugat J, Elosua R. Adding low ankle brachial index to classical risk factors improves the prediction of major cardiovascular events. The REGICOR study.
Atherosclerosis 2015 Aug; 241(2): 357-63
IF: 3.994, Quartile: 1
- Ley M, Principe A, Jiménez-Conde J, Rocamora R. Assessing long-term effects of eslicarbazepine acetate on lipid metabolism profile, sodium values and liver function tests.
Epilepsy Res. 2015 Sep; 115: 147-52
IF: 2.015, Quartile: 3
- Agüero F, González-Zobl G, Baena-Diez JM, Dégano IR, Garcia-Gil M, Alzamora MT, Marrugat J, Comas-Cufí M, Pera G, Elosua R, Ramos R, Grau M. Prevalence of lower extremity peripheral arterial disease in individuals with chronic immune mediated inflammatory disorders.
Atherosclerosis 2015 Sep; 242(1): 1-7
IF: 3.994, Quartile: 1
- Sanchis J, Abellán L, García-Blas S, Mainar L, Mollar A, Valero E, Consuegra-Sanchez L, Roqué M, Bertomeu-González V, Chorro FJ, Núñez E, Núñez J. Usefulness of delta troponin for diagnosis and prognosis assessment of non-ST-segment elevation acute chest pain.
Eur Heart J Acute Cardiovasc Care 2015 Jul;
IF: 15.203, Quartile: 1, Decile: 1
- Martínez-Lizana E, Carmona-Iragui M, Alcolea D, Gómez-Choco M, Vilaplana E, Sánchez-Saudinós MB, Clarimón J, Hernández-Guillamon M, Munuera J, Gelpi E, Gómez-Anson B, de Juan-Delago M, Delgado-Mederos R, Montaner J, Ois A, Amaro S, Blesa R, Martí-Fàbregas J, Lleó A, Fortea J. Cerebral amyloid angiopathy-related atraumatic convexal subarachnoid hemorrhage: an ARIA before the tsunami.
J. Cereb. Blood Flow Metab. 2015 May; 35(5): 710-7
IF: 5.407, Quartile: 1
- de la Torre Hernández JM, Oteo Domínguez JF, Hernández F, Garcia Camarero T, Abdul-Jawad Altisent O, Rivero Crespo F, Cascón JD, Zavala G, Gimeno F, Arrebola Moreno AL, Andraka L, Gómez Menchero A, Bosa F, Carrillo X, Sánchez Recalde Á, Alfonso F, Perez de Prado A, López Palop R, Sanchis J, Diarte de Miguel JA, Jiménez Navarro M, Muñoz L, Ramírez Moreno A, Tizón Marcos H. Dual Antiplatelet Therapy for 6 Months vs 12 Months After New-generation Drug-eluting Stent Implantation: Matched Analysis of ESTROFA-DAPT and ESTROFA-2.
Rev Esp Cardiol (Engl Ed) 2015 Oct; 68(10): 838-45
IF: 3.792, Quartile: 2
- Roldán Rabadán I, Anguita Sánchez M, Marín F, Quesada MA, Camacho Siles J, Peinado R, Bertomeu V, Cequier Fillat A, Badimon L, Muñiz J. Current Antiarrhythmic Therapy for Nonvalvular Atrial Fibrillation in Spain. Data From the FANTASIIA Registry.
Rev Esp Cardiol (Engl Ed) 2015 Jun;
IF: 3.792, Quartile: 2
An initiative of
